182
Views
43
CrossRef citations to date
0
Altmetric
Original Research

Preparation, in vitro release, and pharmacokinetics in rabbits of lyophilized injection of sorafenib solid lipid nanoparticles

, &
Pages 2901-2910 | Published online: 18 Jun 2012

References

  • WilhelmSMCarterCTangLBAY 43-9006 exhibits broad spectrum oral anti-tumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesisCan Res2004641970997109
  • WilhelmSCarterCLynchMDiscovery and development of sorafenib: a multikinase inhibitor for treating cancerNat Rev Drug Discov200651083584417016424
  • MoriSCortesJKantarjianHZhangWAndreefMRavandiFPotential role of sorafenib in the treatment of acute myeloid leukemiaLeuk Lymphoma200849122246225519052971
  • RavandiFCortesJEJoneDPhase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemiaJ Clin Oncol201028111856186220212254
  • LathiaCLettieriJCihonFGallentineMRadtkeMSundaresanPLack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokineticsCancer Chemother Pharmacol200657568569216133532
  • LiYCDongLJiaAChangXMXueHPreparation of solid lipid nanoparticles loaded with traditional Chinese medicine by high-pressure homogenizationSouth Med Univ2006265541544
  • ChenHChangXDuDPodophyllotoxin-loaded solid lipid nanoparticles for epidermal targetingJ Control Release2006110229630616325954
  • LiuJHuWChenHNiQXuHYangXIsotretinoin-loaded solid lipid nanoparticles with skin targeting for topical deliveryInt J Pharm2007328219119516978810
  • BlanchetBBillemontBCramardJValidation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practiceJ Pharm Biomed Anal20094941109111419278805
  • AfifySRappURHoggerPValidation of a liquid chromatography assay for quantification of the Raf kinase inhibitor BAY 43-9006 in small volumes of mouse serumJ Chromatogr B Analyt Technol Biomed Life Sci2004809199103
  • ServiceRFNanomaterials show signs of toxicityScience2003300561724312690169
  • HandyRDHenryTBScownTMJohnstonBDTylerCRManufactured nanoparticles: their uptake and effects on fish-a mechanistic analysisEcotoxicology200817539640918408995
  • ChenJFZhangDRZhangXSXingJPreparation and material phase analysis of solid lipid nanoparticles loading matrineJ Chin Pharm2005364214217
  • LiuJGongTWangCGZhongZZhangZSolid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: Preparation and characterizationInt J Pharm20073401–215316217428627
  • ZhuSSNew Formulation of DrugBeijing, ChinaChemical Industry Press2003435436
  • KuriharaAShibayamaYMizotaAEnhanced tumor delivery and antitumor activity of palmitoyl rhizoxin using stable lipid emulsions in micePharm Res19961323053108932454
  • HancockBCZografiGCharacteristics and significance of the amorphous state in pharmaceutical systemsJ Pharm Sci19978611129002452
  • QinSKGongXLProgress on sorafenib therapy for primary hepatic carcinomaChin Clin Oncol2008131210571068